BRAINSTORM CELL THERAPEUTICS INC. (BCLI)

Latest Insider Confidence Score

2025Q4

50.0
Bullish

Company insider confidence (by quarter)

2003Q4 2025Q4

Largest shareholders

Insider Role (last 12 mo) Shares held Filed at
ACCBT Corp. 10% Owner 10,499,999 Apr 28, 2011
Tel Aviv University — 6,363,849 Sep 17, 2007
Tel Aviv University Economic Corp Ltd — 6,363,849 Sep 11, 2007
Ramot At Tel Aviv University Ltd — 6,363,849 Sep 11, 2007
Natanson Alon — 4,000,000 Feb 1, 2013

Recent buy/sell transactions

Exec date Filing date Insider Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Jan 1, 2025 Jan 7, 2025 Dagher Ibrahim B. Chief Medical Officer Neutral 90.0 +50,000 169.41% ✗ -
Jan 7, 2025 Dagher Ibrahim B. Chief Medical Officer Neutral 52.5 - 0.00% ✗ -
Jan 1, 2025 Jan 3, 2025 Lebovits Chaim CEO Neutral 90.0 +120,000 55.98% ✗ -
Jan 1, 2025 Jan 3, 2025 FRENKEL JACOB A Director Neutral 90.0 +40,000 1059.04% ✗ -
Jan 1, 2025 Jan 3, 2025 Polverino Anthony J. Director Neutral 90.0 +24,000 1387.28% ✗ -
Jan 1, 2025 Jan 3, 2025 Yablonka Uri EVP & Chief Business Officer Neutral 90.0 +60,000 708.88% ✗ -
Jan 1, 2025 Jan 3, 2025 Patlis Alla Officer Neutral 90.0 +40,000 919.75% ✗ -
Jan 1, 2025 Jan 3, 2025 Naor Nir Director Neutral 90.0 +30,666 3838.05% ✗ -
Jan 1, 2025 Jan 3, 2025 Lindborg Stacy Director Neutral 90.0 +20,000 70.85% ✗ -
Jan 1, 2025 Jan 3, 2025 HARTOUNIAN HARTOUN COO Neutral 90.0 +50,000 2500.00% ✗ -
Jan 1, 2025 Jan 3, 2025 Bairu Menghisteab Director Neutral 90.0 +24,000 100.00% ✗ -
Jan 1, 2025 Jan 3, 2025 ARBEL IRIT Director Neutral 90.0 +30,666 295.21% ✗ -
Sep 30, 2024 Oct 2, 2024 Lebovits Chaim CEO Buy 78.8 +23,836 1.73% ✗ $11.3K
May 28, 2024 Jul 31, 2024 Lebovits Chaim CEO Buy 60.0 +15,000 0.48% ✗ $7.8K
May 21, 2024 Jul 31, 2024 Lebovits Chaim CEO Buy 78.8 +50,000 1.61% ✗ $30.5K
May 10, 2024 Jul 31, 2024 Lebovits Chaim CEO Buy 78.8 +40,000 1.31% ✗ $18.9K
May 7, 2024 Jul 31, 2024 Lebovits Chaim CEO Buy 78.8 +66,300 2.21% ✗ $24.8K
May 6, 2024 Jul 31, 2024 Lebovits Chaim CEO Buy 87.5 +135,000 4.72% ✗ $50.7K
Apr 19, 2024 Jul 31, 2024 Lebovits Chaim CEO Buy 67.5 +15,000 0.53% ✗ $7.8K
Apr 17, 2024 Jul 31, 2024 Lebovits Chaim CEO Buy 90.0 +245,072 9.43% ✗ $131.4K
Jul 19, 2024 Jul 24, 2024 Dagher Ibrahim B. Chief Medical Officer Sell 26.3 -63,000 -24.90% ✗ $22.1K
Jun 24, 2024 Jun 25, 2024 HARTOUNIAN HARTOUN COO Neutral 90.0 +30,000 100.00% ✗ -
Jun 25, 2024 HARTOUNIAN HARTOUN COO Neutral 52.5 - 0.00% ✗ -
May 28, 2024 Jun 3, 2024 Lebovits Chaim CEO Neutral 60.0 +15,000 0.48% ✗ -
May 21, 2024 May 23, 2024 Lebovits Chaim CEO Neutral 77.5 +50,000 1.61% ✗ -
May 10, 2024 May 14, 2024 Lebovits Chaim CEO Neutral 77.5 +40,000 1.31% ✗ -
May 7, 2024 May 7, 2024 Lebovits Chaim CEO Neutral 77.5 +66,300 2.21% ✗ -
May 6, 2024 May 7, 2024 Lebovits Chaim CEO Neutral 82.5 +135,000 4.72% ✗ -
Apr 19, 2024 Apr 25, 2024 Lebovits Chaim CEO Neutral 67.5 +15,000 0.53% ✗ -
Apr 22, 2024 Dagher Ibrahim B. Chief Medical Officer Neutral 52.5 - 0.00% ✗ -
Apr 17, 2024 Apr 19, 2024 Lebovits Chaim CEO Neutral 85.0 +245,072 9.43% ✗ -
Mar 11, 2024 Mar 13, 2024 Lindborg Stacy CEO Neutral 90.0 +241,935 133.30% ✗ -
Mar 11, 2024 Mar 13, 2024 Yablonka Uri EVP & Chief Business Officer Neutral 90.0 +109,426 623.76% ✗ -
Mar 11, 2024 Mar 13, 2024 Patlis Alla Officer Neutral 90.0 +65,246 100.00% ✗ -
Mar 11, 2024 Mar 13, 2024 Lebovits Chaim CEO Neutral 90.0 +305,198 13.30% ✗ -
Sep 1, 2023 Sep 5, 2023 Lindborg Stacy CEO Buy 86.3 +11,500 6.76% ✗ $20.4K
Aug 2, 2023 Aug 7, 2023 Lindborg Stacy CEO Neutral 90.0 +35,000 25.93% ✗ -
Aug 2, 2023 Aug 4, 2023 Lebovits Chaim CEO Neutral 77.5 +31,185 1.38% ✗ -
Jun 19, 2023 Jun 21, 2023 Naor Nir Director Neutral 90.0 +11,999 100.00% ✗ -
Jun 21, 2023 Naor Nir Director Neutral 52.5 - 0.00% ✗ -
May 1, 2023 May 1, 2023 Taylor Kirk Chief Medical Officer Neutral 90.0 +35,000 100.00% ✗ -
May 1, 2023 Taylor Kirk Chief Medical Officer Neutral 52.5 - 0.00% ✗ -
Apr 20, 2023 Apr 24, 2023 Lebovits Chaim CEO Neutral 82.5 +75,000 3.43% ✗ -
Apr 20, 2023 Apr 24, 2023 Lindborg Stacy CEO Neutral 90.0 +75,000 125.00% ✗ -
Dec 7, 2022 Jan 4, 2023 Lindborg Stacy CEO Neutral 90.0 +35,000 140.00% ✗ -
Sep 18, 2022 Jan 4, 2023 Lebovits Chaim CEO Neutral 77.5 +31,185 1.45% ✗ -
Apr 6, 2022 Apr 8, 2022 FRENKEL JACOB A Director Neutral 52.5 - 0.00% ✗ -
Mar 6, 2022 Mar 14, 2022 Kern Ralph Dr. COO Neutral 90.0 +35,885 19.15% ✗ -
Feb 1, 2022 Feb 3, 2022 Polverino Anthony J. Director Neutral 90.0 +3,882 17.58% ✗ -
Dec 15, 2021 Dec 17, 2021 TAUB MALCOLM S Director Neutral 90.0 +12,000 18.37% ✗ -
Dec 15, 2021 Dec 17, 2021 Polverino Anthony J. Director Neutral 85.0 +2,000 9.96% ✗ -
Dec 15, 2021 Dec 17, 2021 Almenoff June Sherie Director Neutral 90.0 +2,000 17.90% ✗ -
Dec 15, 2021 Dec 17, 2021 Yablonka Uri Director Neutral 52.5 - 0.00% ✗ -
Dec 15, 2021 Dec 17, 2021 ARBEL IRIT Director Neutral 52.5 - 0.00% ✗ -
Dec 10, 2021 Dec 10, 2021 Kern Ralph Dr. COO Neutral 90.0 +35,885 23.68% ✗ -
Dec 10, 2021 Dec 10, 2021 Lebovits Chaim CEO Neutral 77.5 +31,185 1.47% ✗ -
Dec 10, 2021 Dec 10, 2021 TAUB MALCOLM S Director Neutral 90.0 +12,000 22.50% ✗ -
Dec 10, 2021 Dec 10, 2021 Polverino Anthony J. Director Neutral 90.0 +4,216 26.58% ✗ -
Dec 10, 2021 Dec 10, 2021 ARBEL IRIT Director Neutral 52.5 - 0.00% ✗ -
Dec 10, 2021 Dec 10, 2021 FRENKEL JACOB A Director Neutral 52.5 - 0.00% ✗ -
Dec 10, 2021 Dec 10, 2021 Abbhi Sankesh Director Neutral 60.0 +6,666 0.31% ✗ -
Dec 10, 2021 Dec 10, 2021 Yablonka Uri Director Neutral 52.5 - 0.00% ✗ -
Dec 10, 2021 Dec 10, 2021 Almenoff June Sherie Director Neutral 90.0 +2,000 21.80% ✗ -
Nov 4, 2021 Bairu Menghisteab Director Neutral 52.5 - 0.00% ✗ -
Sep 2, 2021 Patlis Alla Officer Neutral 52.5 - 0.00% ✗ -
Dec 30, 2020 Dec 31, 2020 Shah Preetam CFO Sell 42.5 -25,000 -68.31% ✗ $116K
Nov 17, 2020 Nov 19, 2020 Lindborg Stacy EVP, Head Global Clin Research Neutral 52.5 - 0.00% ✗ -
Sep 8, 2020 Sep 10, 2020 Waclawski Anthony Officer Neutral 90.0 +35,000 100.00% ✗ -
Sep 10, 2020 Waclawski Anthony Officer Neutral 52.5 - 0.00% ✗ -
Jul 26, 2020 Jul 31, 2020 Lebovits Chaim CEO Neutral 77.5 +31,185 1.49% ✗ -
Jul 15, 2020 Jul 16, 2020 Abbhi Sankesh Director Buy 85.0 +46,779 2.20% ✗ $607.7K
Jul 16, 2020 Jul 16, 2020 Setboun David COO Buy 95.0 +5,000 10.00% ✗ $64.7K
Jul 9, 2020 Jul 16, 2020 ACC International Holdings Ltd. Other Sell 20.0 -71,753 -51.69% ✗ $960.7K
Jun 23, 2020 Jun 26, 2020 Yablonka Uri EVP & Chief Business Officer Neutral 90.0 +10,000 132.57% ✗ -
Jun 1, 2020 Jun 1, 2020 Lindborg Stacy EVP, Head Global Clin Research Neutral 90.0 +25,000 100.00% ✗ -
Jun 1, 2020 Lindborg Stacy EVP, Head Global Clin Research Neutral 52.5 - 0.00% ✗ -
Apr 7, 2020 Apr 7, 2020 Setboun David COO Neutral 90.0 +50,000 100.00% ✗ -
Apr 7, 2020 Setboun David COO Neutral 52.5 - 0.00% ✗ -
Apr 6, 2020 Apr 7, 2020 FRENKEL JACOB A Director Neutral 52.5 - 0.00% ✗ -
Apr 7, 2020 FRENKEL JACOB A Director Neutral 52.5 - 0.00% ✗ -
Apr 6, 2020 Apr 7, 2020 Abbhi Sankesh Director Neutral 60.0 +4,657 0.22% ✗ -
Apr 7, 2020 Abbhi Sankesh Director Neutral 52.5 - 0.00% ✗ -
Mar 9, 2020 Mar 13, 2020 Kern Ralph Dr. COO Neutral 52.5 - 0.00% ✗ -
Mar 6, 2020 Mar 6, 2020 Kern Ralph Dr. COO Neutral 90.0 +35,885 31.03% ✗ -
Dec 12, 2019 Feb 14, 2020 Almenoff June Sherie Director Neutral 90.0 +2,000 27.87% ✗ -
Dec 12, 2019 Feb 14, 2020 Polverino Anthony J. Director Neutral 90.0 +5,071 46.99% ✗ -
Dec 12, 2019 Feb 14, 2020 TAUB MALCOLM S Director Neutral 90.0 +12,000 29.03% ✗ -
Dec 12, 2019 Feb 14, 2020 ARBEL IRIT Director Neutral 52.5 - 0.00% ✗ -
Dec 12, 2019 Feb 14, 2020 Yablonka Uri EVP and Chief Business Officer Neutral 52.5 - 0.00% ✗ -
Dec 24, 2019 Dec 27, 2019 Kern Ralph Dr. COO Buy 83.8 +3,000 2.66% ✗ $11.6K
Dec 24, 2019 Dec 27, 2019 Shah Preetam CFO Buy 91.3 +11,600 46.40% ✗ $45.9K
Dec 24, 2019 Dec 27, 2019 Araya Arturo Chief Commercial Officer Buy 91.3 +3,000 53.50% ✗ $11.7K
Sep 6, 2019 Sep 9, 2019 Shah Preetam CFO Neutral 90.0 +25,000 100.00% ✗ -
Sep 9, 2019 Shah Preetam CFO Neutral 52.5 - 0.00% ✗ -
Aug 28, 2019 Aug 30, 2019 ARBEL IRIT Director Sell 26.3 -13,332 -7.88% ✗ $48.9K
Jul 26, 2019 Jul 26, 2019 Lebovits Chaim Officer Neutral 77.5 +31,185 1.46% ✗ -
Mar 6, 2019 Mar 8, 2019 Kern Ralph Dr. COO Neutral 90.0 +35,885 46.74% ✗ -
Feb 1, 2019 Feb 22, 2019 Polverino Anthony J. Director Neutral 90.0 +3,501 48.02% ✗ -
Jan 4, 2019 Jan 8, 2019 Almenoff June Sherie Director Buy 90.0 +1,475 25.88% ✗ $5K
Oct 24, 2018 Dec 21, 2018 Schor Chen Director Neutral 52.5 - 0.00% ✗ -